IL116082A0 - Oxazoles their preparation and pharmaceutical compositions containing them - Google Patents

Oxazoles their preparation and pharmaceutical compositions containing them

Info

Publication number
IL116082A0
IL116082A0 IL11608295A IL11608295A IL116082A0 IL 116082 A0 IL116082 A0 IL 116082A0 IL 11608295 A IL11608295 A IL 11608295A IL 11608295 A IL11608295 A IL 11608295A IL 116082 A0 IL116082 A0 IL 116082A0
Authority
IL
Israel
Prior art keywords
oxazoles
preparation
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL11608295A
Other languages
English (en)
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9423638A external-priority patent/GB9423638D0/en
Priority claimed from GBGB9506282.4A external-priority patent/GB9506282D0/en
Priority claimed from GBGB9519885.9A external-priority patent/GB9519885D0/en
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of IL116082A0 publication Critical patent/IL116082A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11608295A 1994-11-23 1995-11-21 Oxazoles their preparation and pharmaceutical compositions containing them IL116082A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9423638A GB9423638D0 (en) 1994-11-23 1994-11-23 Antagonists of a- 1c adrenergic receptors
GBGB9506282.4A GB9506282D0 (en) 1995-03-28 1995-03-28 Antagonists of A-1C adrenergic receptors
GBGB9519885.9A GB9519885D0 (en) 1995-09-29 1995-09-29 Antagonists of a-1 adrenergic receptors

Publications (1)

Publication Number Publication Date
IL116082A0 true IL116082A0 (en) 1996-01-31

Family

ID=27267484

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11608295A IL116082A0 (en) 1994-11-23 1995-11-21 Oxazoles their preparation and pharmaceutical compositions containing them

Country Status (8)

Country Link
US (1) US6090825A (fr)
EP (1) EP0793658A1 (fr)
JP (1) JPH10509713A (fr)
AR (1) AR002249A1 (fr)
AU (1) AU4174096A (fr)
IL (1) IL116082A0 (fr)
PE (1) PE52796A1 (fr)
WO (1) WO1996016049A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055143A1 (fr) * 1999-03-17 2000-09-21 F. Hoffmann-La Roche Ag Derives d'oxazolone et utilisations de ces derniers en tant que modulateurs du recepteur adrenergique alpha-1
US6355641B1 (en) 1999-03-17 2002-03-12 Syntex (U.S.A.) Llc Oxazolone derivatives and uses thereof
US20040216749A1 (en) * 2003-01-23 2004-11-04 Hosheng Tu Vasomodulation during glaucoma surgery
CN1980901A (zh) * 2004-06-30 2007-06-13 万有制药株式会社 联芳基衍生物
WO2010080873A1 (fr) * 2009-01-08 2010-07-15 Glaxo Group Limited Oxazoles en tant que modulateurs des récepteurs de la chimiokine
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
JP2017100949A (ja) * 2014-04-01 2017-06-08 大日本住友製薬株式会社 ５員環ヘテロアリール誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1033040B (it) * 1970-02-21 1979-07-10 Serono Ist Farm 4 5 difenilossazoli 2 amminometil e 2,2 amminoetil sostituiti
US3966748A (en) * 1975-05-08 1976-06-29 American Cyanamid Company Para-fluorophenyl-N-heterocyclic substituted butanes
US4101660A (en) * 1976-02-12 1978-07-18 Mitsubishi Chemical Industries Limited 2-Aminomethyl-5-phenyloxazoles and the pharmaceutically acceptable acid addition salts thereof
US5324723A (en) * 1987-09-10 1994-06-28 Merck Sharpe & Dohme Ltd. Oxazoles and thiazoles for the treatment of senile dementia
ES2125285T3 (es) * 1992-07-31 1999-03-01 Bristol Myers Squibb Co Derivados inhibidores de la reabsorcion de adenosina de difenil-oxazoles, tiazoles e imidazoles.

Also Published As

Publication number Publication date
US6090825A (en) 2000-07-18
PE52796A1 (es) 1996-12-25
AR002249A1 (es) 1998-03-11
AU4174096A (en) 1996-06-17
WO1996016049A1 (fr) 1996-05-30
EP0793658A1 (fr) 1997-09-10
JPH10509713A (ja) 1998-09-22

Similar Documents

Publication Publication Date Title
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL114626A0 (en) 6-membered nitrogen-containing heteroaryl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL119995A0 (en) Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL114578A0 (en) Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use
IL114759A (en) Benzoxazole derivatives and pharmaceutical compositions containing them
IL117860A0 (en) Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL121235A0 (en) Bicyclic-fused pyridines their preparation and pharmaceutical compositions containing them
IL114492A0 (en) Benzimidazole derivatives their preparation and pharmaceutical compositions containing them
IL122293A0 (en) Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL114795A (en) N-benzylindole-and benzopyrazole derivatives their preparation and pharmaceutical compositions containing them
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL114925A0 (en) Glycinamide derivatives their preparation and pharmaceutical compositions containing them
IL115905A0 (en) Sordarin derivatives their preparation and pharmaceutical compositions containing them
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL112889A0 (en) Beta-lactams their preparation and pharmaceutical compositions containing them
IL117815A0 (en) Ascomycins their preparation and pharmaceutical compositions containing them
IL114572A0 (en) Benzamine pharmaceutical compositions containing it its preparation and use
IL115027A (en) N-substituted phenothiazines their preparation pharmaceutical compositions containing them and their use
IL125998A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing them
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
IL118672A0 (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them